癌症细胞降解纳米粒子蛋白冠状病毒的生物合成
Qin Ji1,2,3, Colin Blackadar1,2,3, Atta C Y Chang1,2,3
1Institute of Biomedical Engineering, University of Toronto, Rosebrugh Building, Toronto, Ontario M5S 3G9, Canada.
Journal of the American Chemical Society
|February 25, 2026
概括
癌症细胞将纳米粒子蛋白质冠冕代谢成用于生物合成的氨基酸. 这揭示了蛋白质冠状体作为营养储备,增强癌细胞代谢和宏分子合成.
科学领域:
- 生物医学工程 生物医学工程
- 癌症生物学 癌症生物学
- 纳米医学是一种纳米医学.
背景情况:
- 纳米粒子用于癌症检测和治疗.
- 蛋白质冠状体在血液中的纳米颗粒上形成,影响它们的行为.
- 细胞吸收后蛋白冠的命运还不清楚.
研究的目的:
- 为了研究癌细胞内蛋白冠的代谢命运.
- 为了确定癌细胞是否利用蛋白质冠冕进行生物合成.
主要方法:
- 纳米颗粒与蛋白质冠状体内化进入癌细胞.
- 追踪纳米粒子和蛋白质冠状运输到 lysosomes.
- 对蛋白质冠状体降解和副产品利用的分析.
主要成果:
- 癌细胞将蛋白质冠状体降解为溶酶体内的氨基酸.
- 这些氨基酸用于合成新的宏分子.
- 内化纳米粒子提供大量的蛋白质,超过溶液吸收.
结论:
- 纳米颗粒蛋白冠状体作为癌细胞的营养储存库.
- 这种新陈代谢过程支持癌细胞的生物合成和巨分子的产生.
- 这些发现突出了冠状蛋白在癌细胞代谢中的新作用.
更多相关视频
07:54Capillary Electrophoresis Mass Spectrometry Approaches for Characterization of the Protein and Metabolite Corona Acquired by Nanomaterials
Published on: October 27, 2020
4.9K
10:24A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
Published on: January 27, 2026
302
相关概念视频
Adaptive Mechanisms in Cancer Cells
7.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.2K
The Nucleolus
10.5K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
10.5K
Cancer Cell Migration through Invadopodia
3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K
Cancer Stem Cells and Tumor Maintenance
6.1K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.1K
The Proteasome
10.4K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.4K
Cancer-Critical Genes I: Proto-oncogenes
11.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.6K
